[1]
|
Gracia-Sancho, J., Marrone, G. and Fernández-Iglesias, A. (2019) Hepatic Microcirculation and Mechanisms of Portal Hypertension. Nature Reviews Gastroenterology & Hepatology, 16, 221-234.
https://doi.org/10.1038/s41575-018-0097-3
|
[2]
|
Li, S., Huang, N., Dang, X., et al. (2020) A Comparison of Splenic Pathologic Change and Immune Function in HBV-Related Portal Hypertension and Chinese Budd-Chiari Syn-drome Patients with Hypersplenism. Viral Immunology, 2020, 33, 112-121. https://doi.org/10.1089/vim.2019.0146
|
[3]
|
De Franchis, R., Bosch, J., Garcia-Tsao, G., et al. (2022) Baveno VII—Renewing Consensus in Portal Hypertension. Journal of Hepatology, 76, 959-974. https://doi.org/10.1016/j.jhep.2021.12.022
|
[4]
|
Garcia-Tsao, G., Abraldes, J.G., Berzigotti, A. and Bosch, J. (2017) Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis, and Management: 2016 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology, 65, 310-335. https://doi.org/10.1002/hep.28906
|
[5]
|
Yu, Q., Huang, Y., Li, X., et al. (2022) An Imaging-Based Artificial Intel-ligence Model for Non-Invasive Grading of Hepatic Venous Pressure Gradient in Cirrhotic Portal Hypertension. Cell Reports Medicine, 3, Article ID: 100563.
https://doi.org/10.1016/j.xcrm.2022.100563
|
[6]
|
Qi, X., Berzigotti, A., Cardenas, A. and Sarin, S.K. (2018) Emerging Non-Invasive Approaches for Diagnosis and Monitoring of Portal Hypertension. The Lancet Gastroenterolo-gy and Hepatology, 3, 708-719.
https://doi.org/10.1016/S2468-1253(18)30232-2
|
[7]
|
Kennedy, P., Bane, O., Hectors, S.J., et al. (2020) Noninva-sive Imaging Assessment of Portal Hypertension. Abdominal Radiology, 45, 3473-3495. https://doi.org/10.1007/s00261-020-02729-7
|
[8]
|
Yu, Q., Xu, C., Li, Q., et al. (2022) Spleen Volume-Based Non-Invasive Tool for Predicting Hepatic Decompensation in People with Compensated Cirrhosis (CHESS1701). JHEP Reports, 4, Article ID: 100575.
https://doi.org/10.1016/j.jhepr.2022.100575
|
[9]
|
Reiniš, J., Petrenko, O., Simbrunner, B., et al. (2023) Assessment of Portal Hypertension Severity Using Machine Learning Models in Patients with Compensated Cirrhosis. Journal of Hepatology, 78, 390-400.
https://doi.org/10.1016/j.jhep.2022.09.012
|
[10]
|
Berzigotti, A., Seijo, S., Arena, U., et al. (2013) Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients with Compensated Cirrhosis. Gastroenterology, 144, 102-111.E1.
https://doi.org/10.1053/j.gastro.2012.10.001
|
[11]
|
Dajti, E., Ravaioli, F., Zykus, R., et al. (2023) Accuracy of Spleen Stiffness Measurement for the Diagnosis of Clinically Significant Portal Hypertension in Patients with Compen-sated Advanced Chronic Liver Disease: A Systematic Review and Individual Patient Data Meta-Analysis. The Lancet Gastroenterology and Hepatology, 8, 816-828.
https://doi.org/10.1016/S0168-8278(23)00867-X
|
[12]
|
Jindal, A., Sharma, S., Agarwal, S., et al. (2022) Liver Stiffness Can Predict Decompensation and Need for β-Blockers in Compensated Cirrhosis: A Step beyond Baveno-VI Criteria. Hepatology International, 16, 89-98.
https://doi.org/10.1007/s12072-021-10280-w
|
[13]
|
Semmler, G., Lens, S., Meyer, E.L., et al. (2022) Non-Invasive Tests for Clinically Significant Portal Hypertension after HCV Cure. Journal of Hepatology, 77, 1573-1585. https://doi.org/10.1016/j.jhep.2022.08.025
|
[14]
|
Marasco, G., Colecchia, A., Colli, A., et al. (2019) Role of Liver and Spleen Stiffness in Predicting the Recurrence of Hepatocellular Carcinoma after Resection. Journal of Hepatology, 70, 440-448.
https://doi.org/10.1016/j.jhep.2018.10.022
|
[15]
|
Ripoll, C. and Zipprich, A. (2023) Spleen Stiffness to Identify Clinically Significant Portal Hypertension. The Lancet Gastroenterology and Hepatology, 8, 775-776. https://doi.org/10.1016/S2468-1253(23)00189-9
|
[16]
|
Sartoris, R., Rautou, P.E., Elkrief, L., et al. (2018) Quantifi-cation of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension. Radiology, 289, 698-707. https://doi.org/10.1148/radiol.2018181131
|
[17]
|
Shi, Y., Qi, Y.F., Lan, G.Y., et al. (2021) Three-Dimensional MR Elastography Depicts Liver Inflammation, Fibrosis, and Portal Hypertension in Chronic Hepatitis B or C. Radiology, 301, 154-162.
https://doi.org/10.1148/radiol.2021202804
|
[18]
|
Liu, C., Cao, Z., Yan, H., et al. (2022) A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multi-center Cohort Study. The American Journal of Gastroenterology, 117, 1605-1613. https://doi.org/10.14309/ajg.0000000000001873
|
[19]
|
Wang, L., Zhang, Y., Wu, Y.F., et al. (2022) Computed Tomography Perfusion in Liver and Spleen for Hepatitis B Virus-Related Portal Hypertension: A Correlation Study with Hepatic Venous Pressure Gradient. World Journal of Gastroenterology, 28, 6068-6077. https://doi.org/10.3748/wjg.v28.i42.6068
|
[20]
|
尤红, 王福生, 李太生, 等. 慢性乙型肝炎防治指南(2022年版) [J]. 实用肝脏病杂志, 2023, 26(3): 457-478.
|
[21]
|
徐小元, 丁惠国, 李文刚, 等. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425.
|
[22]
|
中国门静脉高压诊断与监测研究组(CHESS), 中华医学会消化病学分会微创介入协作组, 中国医师协会介入医师分会急诊介入专业委员会, 等. 中国肝静脉压力梯度临床应用专家共识(2018版) [J]. 临床肝胆病杂志, 2018, 34(12): 2526-2536.
|
[23]
|
Xiao, J., Wang, F., Wong, N.K., et al. (2019) Global Liver Disease Burdens and Research Trends: Analysis from a Chinese Perspective. Journal of Hepatology, 71, 212-221. https://doi.org/10.1016/j.jhep.2019.03.004
|
[24]
|
Hectors, S.J., Bane, O., Stocker, D., et al. (2020) Splenic T(1ρ) as a Noninvasive Biomarker for Portal Hypertension. Journal of Magnetic Resonance Imaging, 52, 787-794. https://doi.org/10.1002/jmri.27087
|
[25]
|
Kumar, A., Khan, N.M., Anikhindi, S.A., et al. (2017) Correlation of Transient Elastography with Hepatic Venous Pressure Gradient in Patients with Cirrhotic Portal Hypertension: A Study of 326 Patients from India. World Journal of Gastroenterology, 23, 687-696. https://doi.org/10.3748/wjg.v23.i4.687
|
[26]
|
Dietrich, C.F., Bamber, J., Berzigotti, A., et al. (2017) EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version). Ultraschall in der Medizin, 38, 377-394.
https://doi.org/10.1055/s-0043-103955
|
[27]
|
Kim, G., Kim, M.Y. and Baik, S.K. (2017) Transient Elastography versus Hepatic Venous Pressure Gradient for Diagnosing Portal Hypertension: A Systematic Review and Meta-Analysis. Clinical and Molecular Hepatology, 23, 34-41. https://doi.org/10.3350/cmh.2016.0059
|
[28]
|
Kumar, A., Maruyama, H., Arora, A., et al. (2022) Diagnostic Accuracy of Transient Elastography in Diagnosing Clinically Significant Portal Hypertension in Patients with Chronic Liver Disease: A Systematic Review and Meta-Analysis. Journal of Medical Ul-trasonics, 49, 333-346. https://doi.org/10.1007/s10396-022-01239-x
|
[29]
|
Kuszajewski, M.L. and Clontz, A.S. (2005) Prealbumin Is Best for Nutritional Monitoring. Nursing, 35, 70-71.
https://doi.org/10.1097/00152193-200505000-00056
|
[30]
|
Tapper, E.B. and Parikh, N.D. (2023) Diagnosis and Management of Cirrhosis and Its Complications: A Review. JAMA, 329, 1589-1602. https://doi.org/10.1001/jama.2023.5997
|
[31]
|
郁沙莎, 潘波, 郭玉玉, 等. 血清前白蛋白(PA)含量在肝脏TACE术患者预后中的临床价值[J]. 现代肿瘤医学, 2019, 27(2): 278-280.
|
[32]
|
Zhai, Y.Z., Yue, Y.Y., Ding, D.P., et al. (2017) [The Value of Serum Prealbumin Combined with MELD Score in Predicting the Prognosis of Patients with De-compensated Cirrhosis]. Chinese Journal of Hepatology, 25, 533-535.
|
[33]
|
Dumont, C., Wuestenberghs, F., Lanthier, N., et al. (2022) Malnutrition Is Highly Prevalent in Hospitalized Cirrhotic Patients and Associates with a Poor Outcome. Acta Gastro-Enterologica Belgica, 85, 311-319.
https://doi.org/10.51821/85.2.9016
|
[34]
|
Dağ, Z., Köseoğlu, H. and Kekilli, M. (2020) The Use of Prealbumin as a Predictor of Malnutrition in Cirrhotic Patients and the Effect of Nutritional Support in Patients with Low Prealbumin Levels. Turkish Journal of Medical Sciences, 50, 398-404. https://doi.org/10.3906/sag-1910-27
|
[35]
|
Gao, W., Kong, M., Yao, J., et al. (2018) Changes in Prealbumin and Body Mass Index Associated with T Lymphocyte Subsets and Nutritional Status in Chronic Hepatitis B and HBV-Cirrhosis Patients. Clinical Laboratory, 64.
https://doi.org/10.7754/Clin.Lab.2018.180501
|
[36]
|
Stefanescu, H., Marasco, G., Calès, P., et al. (2020) A Novel Spleen-Dedicated Stiffness Measurement by FibroScan® Improves the Screening of High-Risk Oesophageal Varices. Liver International, 40, 175-185.
https://doi.org/10.1111/liv.14228
|
[37]
|
Deng, H., Qi, X. and Guo, X. (2015) Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Medicine, 94, e1795. https://doi.org/10.1097/MD.0000000000001795
|
[38]
|
Kalambokis, G.N., Oikonomou, A., Christou, L., et al. (2016) von Willebrand Factor and Procoagulant Imbalance Predict Outcome in Patients with Cirrhosis and Thrombocytopenia. Journal of Hepatology, 65, 921-928.
https://doi.org/10.1016/j.jhep.2016.06.002
|
[39]
|
Lisotti, A., Azzaroli, F., Cucchetti, A., et al. (2016) Relationship between Indocyanine Green Retention Test, Decompensation and Survival in Patients with Child-Pugh A Cirrhosis and Portal Hypertension. Liver International, 36, 1313-1321. https://doi.org/10.1111/liv.13070
|
[40]
|
Dajti, E., Alemanni, L.V., Marasco, G., Montagnani, M. and Azzaroli, F. (2021) Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? Hepatic Medicine: Evidence and Research, 13, 25-36.
https://doi.org/10.2147/HMER.S278077
|